Botulinum Toxin Injections for Thoracic Outlet Syndrome

PHASE1UnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

June 30, 2013

Conditions
Thoracic Outlet Syndrome
Interventions
DRUG

Botulinum Toxin Type A

Botulinum Toxin Type A 100 units injected under EMG guidance one time into the anterior,middle scalenes and pectoralis minor muscle

OTHER

Normal Saline injection

10 cc of Normal Saline will be injected under EMG guidance into the Anterior and Middle Scalenes and Pectoralis Minor muscle of individual diagnosed with Thoracic Outlet Syndrome.

Trial Locations (1)

V5Z-2G9

G F Strong Rehabilitation Centre, Vancouver

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Merz Pharmaceuticals

INDUSTRY

lead

University of British Columbia

OTHER